Senior Director, VP of Finance
SiteOne Therapeutics
Summary
SiteOne Therapeutics is seeking an experienced Senior Director or VP of Finance to lead our Financial Planning & Analysis functions. The scope of work includes oversight of accounting, financial reporting, internal control, annual budgeting and long-range planning, financial analysis, banking, insurance and risk management, stock plan administration, tax and treasury.
Key Responsibilities
- Lead Accounting and Financial Planning & Analysis activities
- Prepare financial reports, analyses and other materials for our leadership team and board of directors
- Lead our annual budgeting process and our long-range financial planning process. Analyze, understand and report on key financial trends and variances. Conduct ad hoc financial analyses in support of business development and other company initiatives
- Implement scalable systems to improve workflows
- Participate in senior leadership team meetings and in key internal committees, including development program teams
- Manage annual financial audit and relationship with auditors
- Manage the company’s cash and ensure compliance with the company’s investment policy; manage insurance
- Coordinate corporate tax reporting and tax return preparation with outside accountants
- Research relevant technical issues and recommendation of accounting treatment
Qualifications
- Undergraduate degree in accounting, finance or another relevant discipline is required
- CPA credential and/or public accounting experience preferred
- 10+ years of progressive growth in financial roles in biotechnology/pharmaceutical companies, including at least 5 years in financial leadership roles
- Familiarity with ERP systems required; experience with QuickBooks and NetSuite is a plus
- Experience with public company reporting including 10Ks and 10Qs
- Strong Excel and financial modeling skills
About SiteOne Therapeutics
SiteOne Therapeutics is a clinical-stage biopharmaceutical company advancing a novel class of highly selective small molecule inhibitors targeting NaV1.7, NaV1.8, and other ion channels to treat peripheral hypersensitivity disorders such as chronic cough, itch, and pain. Since its inception, SiteOne has been dedicated to the development of safe and effective pain therapeutics without the significant addiction potential and side effects of opioids. The company’s website can be found at www.siteonetherapeutics.com.